Nanoscopic biodosimetry using plasmid DNA in radiotherapy with metallic nanoparticles.


Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
Feb 2023
Historique:
revised: 08 09 2022
received: 10 05 2022
accepted: 02 12 2022
pubmed: 23 12 2022
medline: 15 2 2023
entrez: 22 12 2022
Statut: ppublish

Résumé

Nanoscopic lesions (complex damages), are the most lethal lesions for the cells. As nanoparticles have become increasingly popular in radiation therapy and the importance of analyzing nanoscopic dose enhancement has increased, a reliable tool for nanodosimetry has become indispensable. In this regard, the DNA plasmid is a widely used tool as a nanodosimetry probe in radiobiology and nano-radiosensitization studies. This approach is helpful for unraveling the radiosensitization role of nanoparticles in terms of physical and physicochemical effects and for quantifying radiation-induced biological damage. This review discusses the potential of using plasmid DNA assays for assessing the relative effects of nano-radiosensitizers, which can provide a theoretical basis for the development of nanoscopic biodosimetry and nanoparticle-based radiotherapy.

Identifiants

pubmed: 36546569
doi: 10.1002/acm2.13879
pmc: PMC9924121
doi:

Substances chimiques

Radiation-Sensitizing Agents 0
DNA 9007-49-2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13879

Subventions

Organisme : Research Center of Tabriz University of Medical Science
ID : 66155/IR.TBZMED.VCR.REC.1399.438

Informations de copyright

© 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.

Références

Rep Pract Oncol Radiother. 2010 Oct 08;15(6):176-80
pubmed: 24376946
J Am Chem Soc. 2003 Apr 16;125(15):4467-77
pubmed: 12683817
Cancer Nanotechnol. 2016;7(1):8
pubmed: 27867425
Opt Express. 2007 Jan 22;15(2):754-9
pubmed: 19532298
Appl Phys Lett. 2011 May 9;98(19):193702
pubmed: 21915155
Phys Med Biol. 2012 Dec 21;57(24):8309-23
pubmed: 23201628
Med Phys. 2020 Feb;47(2):651-661
pubmed: 31725910
Int J Radiat Biol. 2005 Jul;81(7):515-22
pubmed: 16263655
Toxicol Sci. 2011 Mar;120 Suppl 1:S130-45
pubmed: 21163908
Radiat Environ Biophys. 2014 Nov;53(4):705-12
pubmed: 25034012
Int J Radiat Biol. 2008 Jan;84(1):23-33
pubmed: 17852554
Int J Mol Sci. 2019 Nov 12;20(22):
pubmed: 31718091
Nucleic Acids Res. 2012 Jul;40(13):6060-9
pubmed: 22467205
Sci Rep. 2013;3:2234
pubmed: 23868657
Radiat Prot Dosimetry. 2019 May 1;183(1-2):89-92
pubmed: 30534982
J Phys Chem B. 2011 Apr 28;115(16):4843-55
pubmed: 21473599
J Radiat Res. 2022 Mar 17;63(2):255-260
pubmed: 34952540
Int J Radiat Biol. 1997 Apr;71(4):347-63
pubmed: 9154139
Phys Med Biol. 2004 Sep 21;49(18):N309-15
pubmed: 15509078
Nucl Med Biol. 2021 Sep-Oct;100-101:36-43
pubmed: 34153932
Clin Oncol (R Coll Radiol). 2013 Oct;25(10):578-85
pubmed: 23849504
Radiat Environ Biophys. 2007 Jun;46(2):147-54
pubmed: 17072633
Nanotechnology. 2011 Nov 18;22(46):465101
pubmed: 22024607
Radiat Res. 2008 Jan;169(1):19-27
pubmed: 18159957
Phys Rev Lett. 2006 Jun 23;96(24):243203
pubmed: 16907238
Sci Rep. 2019 May 31;9(1):8156
pubmed: 31148555
Int J Radiat Biol. 2019 Nov;95(11):1484-1497
pubmed: 31290712
Nanotechnology. 2010 Feb 26;21(8):85103
pubmed: 20101074
Radiat Prot Dosimetry. 2019 Dec 31;186(2-3):168-171
pubmed: 31803909
ACS Nano. 2019 May 28;13(5):5077-5090
pubmed: 31009200
Nanomaterials (Basel). 2020 May 17;10(5):
pubmed: 32429500
Nucleic Acids Res. 2020 Feb 20;48(3):e18
pubmed: 31840169
Phys Med Biol. 2009 Aug 7;54(15):4705-21
pubmed: 19590119
Int J Radiat Biol. 2017 Aug;93(8):757-763
pubmed: 28452253
J Phys Chem B. 2007 Oct 11;111(40):11622-5
pubmed: 17854220
Radiat Environ Biophys. 2015 Aug;54(3):343-52
pubmed: 26007308
Nanomedicine. 2014 Nov;10(8):1601-8
pubmed: 24846523
Radiat Res. 2001 Nov;156(5 Pt 2):590-3
pubmed: 11604077
Int J Nanomedicine. 2016 Apr 15;11:1549-56
pubmed: 27143877
J Appl Clin Med Phys. 2023 Feb;24(2):e13879
pubmed: 36546569
Radiat Res. 1994 Mar;137(3):295-9
pubmed: 8146271
RSC Adv. 2019 Feb 28;9(12):6845-6858
pubmed: 35518487
Radiat Res. 2005 Dec;164(6):755-65
pubmed: 16296881
Radiat Environ Biophys. 2012 Mar;51(1):43-52
pubmed: 21964719
Br J Radiol. 2016;89(1059):20150200
pubmed: 26642305
Med Phys. 2019 Nov;46(11):5314-5325
pubmed: 31505039
J Am Chem Soc. 2012 Feb 1;134(4):1950-3
pubmed: 22260210
Radiat Res. 2012 May;177(5):614-27
pubmed: 22206232
Radiat Res. 2007 Sep;168(3):357-66
pubmed: 17705639
Int J Radiat Biol. 2000 Jul;76(7):881-90
pubmed: 10923612
Int J Radiat Biol. 2019 Jan;95(1):64-75
pubmed: 30247087
PLoS One. 2018 Jan 18;13(1):e0190183
pubmed: 29346397
Radiat Res. 2018 Oct;190(4):404-411
pubmed: 30016217
J Radiat Res. 2009 Jan;50(1):27-36
pubmed: 19218779
Int J Radiat Biol. 2007 Sep;83(9):569-76
pubmed: 17654098
Science. 2000 Mar 3;287(5458):1658-60
pubmed: 10698742
Cancers (Basel). 2021 Jun 25;13(13):
pubmed: 34202342
Radiat Prot Dosimetry. 2002;99(1-4):143-5
pubmed: 12194267
Nanomedicine. 2011 Oct;7(5):604-14
pubmed: 21333754
Int J Mol Sci. 2019 Sep 01;20(17):
pubmed: 31480532
Phys Med Biol. 2005 Aug 7;50(15):N163-73
pubmed: 16030374
Small. 2008 Feb;4(2):288-94
pubmed: 18247386
Theranostics. 2018 Feb 12;8(7):1824-1849
pubmed: 29556359
Int J Nanomedicine. 2021 Jan 14;16:359-370
pubmed: 33469290
Colloids Surf B Biointerfaces. 2019 Mar 1;175:606-613
pubmed: 30580151
Chem Commun (Camb). 2005 Jul 7;(25):3192-4
pubmed: 15968368
Environ Toxicol Pharmacol. 2018 Mar;58:230-236
pubmed: 29428683
Int J Nanomedicine. 2019 Dec 18;14:9941-9954
pubmed: 31908451
Eur Respir J. 2008 Feb;31(2):241-51
pubmed: 18057054
Cancer Nanotechnol. 2017;8(1):9
pubmed: 29213338
J Radiat Res. 2002 Dec;43 Suppl:S149-52
pubmed: 12793749
Phys Med Biol. 2019 Aug 28;64(17):175005
pubmed: 31295730
Z Naturforsch C J Biosci. 1997 May-Jun;52(5-6):364-72
pubmed: 9232893
Nanoscale. 2017 May 11;9(18):5843-5853
pubmed: 28429022
Int J Radiat Biol. 1995 Jul;68(1):1-9
pubmed: 7629431
J Am Chem Soc. 2002 Jul 31;124(30):8859-66
pubmed: 12137539
Sci Rep. 2021 Feb 8;11(1):3341
pubmed: 33558553
Colloids Surf B Biointerfaces. 2009 Aug 1;72(1):128-34
pubmed: 19414242
Cancers (Basel). 2020 Mar 26;12(4):
pubmed: 32225023
Phys Med Biol. 2014 Mar 21;59(6):1441-58
pubmed: 24584098
Med Phys. 2015 Nov;42(11):6703-10
pubmed: 26520760
Int J Radiat Biol. 2005 Jan;81(1):41-54
pubmed: 15962762
Br J Radiol. 2014 Sep;87(1041):20140134
pubmed: 24990037
Radiat Res. 2008 Sep;170(3):381-7
pubmed: 18763863
Sci Rep. 2011;1:18
pubmed: 22355537
Nanoscale. 2017 Nov 30;9(46):18413-18422
pubmed: 29148554

Auteurs

Elham Mansouri (E)

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Asghar Mesbahi (A)

Molecular Medicine Research Center, Institute of Biomedicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Medical Physics Department, Medical School, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad Saied Hejazi (MS)

Molecular Medicine Research Center, Institute of Biomedicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Soheila Montazersaheb (S)

Molecular Medicine Research Center, Institute of Biomedicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Vahideh Tarhriz (V)

Molecular Medicine Research Center, Institute of Biomedicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Tohid Ghasemnejad (T)

Molecular Medicine Research Center, Institute of Biomedicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Mojtaba Zarei (M)

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH